Showing 691-700 of 1478 results for "".
One to Watch: Jessica Schiffbauer, OD, FAAO, Dipl ABO
https://modernod.com/topics/human-interest/one-to-watch-jessica-schiffbauer-od-faao-dipl-abo/38545/62. Burnout and When to Get Out ft. Dr. Jasdeep Soni
https://modernod.com/podcasts/four-eyes/62-burnout-and-when-to-get-out-ft-dr-jasdeep-soni/37012/Dr. Jasdeep Soni, also known as Optoturban on social media, returns to the podcast to share his personal experience with burnout through his optometric career and social media presence, and the steps he has taken to address mental fatigue. Dr. Bilkhu and Dr. Kar contribute to the conversation to briEye Care for Pregnant and Postpartum Patients
https://modernod.com/topics/patient-care/eye-care-for-pregnant-and-postpartum-patients/38533/A guide for identifying eye- and vision-related changes in this population and supporting their needs.Retina Therapeutic Roundup
https://modernod.com/topics/retina/retina-therapeutic-roundup/38526/An overview of promising new drugs targeting diseases that threaten the sight of our patients.Global Perspectives With Roya Habibi, OD, FAAO, FSLS
https://modernod.com/topics/human-interest/global-perspectives-with-roya-habibi-od-faao-fsls/38525/The Referral Conundrum
https://modernod.com/mod-issues/2022-oct/the-referral-conundrum/39128/When in doubt about a keratoconus suspect, refer them—you could be saving their sight.Treating Glaucoma in the Cataract Patient
https://modernod.com/mod-issues/2022-oct/treating-glaucoma-in-the-cataract-patient/38511/Combining treatments for both conditions has several benefits.Based on a presentation at MOD Live 2022 in Nashville, Tennessee.Where Are We Going With IOL Technology?
https://modernod.com/topics/technology/where-are-we-going-with-iol-technology/38510/A review of new and potential options for cataract surgery.One More Issue, if You Please
https://modernod.com/mod-issues/2022-sept/one-more-issue-if-you-please/38497/The diagnosis and management of uveitis can be complicated.Drops, Drops, Drops!
https://modernod.com/topics/ocular-surface/drops-drops-drops/38492/New pharmaceutical agents allow clinicians to rethink the way patients are treated.